Juan Spínelli

Juan Spínelli

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition
Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.
Nebraska Medical Cannabis Legalization Heads Into November Election Amid Signature Controversy
Nebraska voters will decide on medical cannabis legalization in November, despite fraud allegations and legal challenges surrounding petition signatures.
Marijuana Sales Hit Record Highs In These 6 US States: Is Marijuana Outpacing Alcohol?
Six U.S. states set new monthly marijuana sales records in August, led by Michigan's $295M. Rising cannabis demand continues to reshape the industry.
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?
New research suggests psilocybin mushrooms may have shaped human consciousness, supporting the Stoned Ape Hypothesis and sparking evolutionary leaps
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
LSD, MDMA And d-Amphetamine: Study Provides New Insights Into Neurobiological Effects
A new study reveals how LSD, MDMA and d-amphetamine affect brain connectivity, offering insights into their distinct & shared mechanisms.
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
MAPS shifts focus to state-level MDMA therapy legalization after FDA denial, advocating for ballot measures in states like Colorado, Oregon, and Massachusetts.
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.
Biden Administration Finalizes Rule To Expand Mental Health Care Access: How This Could Impact The Psychedelics Industry
Biden's new mental health rule expands access to treatment, including potential insurance coverage for psychedelic-assisted therapies, shaping the future of mental health care.
UK Government Drug Ban Targets 'Zombie Drug' Xylazine And Other Opioids
UK bans "zombie drug" xylazine and 21 other substances in new legislation, aiming to curb drug deaths and target criminal gangs.
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
Moxy, a powerful psychedelic, is gaining global momentum. With new FDA approved trials investigating its potential to treat mental health conditions, Moxy is poised to become a key player in the psychedelic space.
Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care
Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.
When Psychedelics Go Wrong: Inside Berlin's Specialized Clinic For Psychedelic Side Effects
Berlin's clinic for psychedelic difficulties helps patients with conditions like HPPD, anxiety and derealization after drug use.
How Set And Setting Impact The Effects Of LSD, New Study Sheds Light
New research finds that LSD effects are shaped by dose, mood, and personality traits, offering insights into optimizing psychedelic therapy.
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI advancements in drug development.
Athletes Embrace Psychedelic Therapy For Concussion Symptoms, More Than One-Third Say It Helps
The Night Eric Clapton Was Slipped LSD: Guitarist George Terry On The Chaos Of Touring In The '70s
George Terry Reflects on Stepping In for Eric Clapton During the Guitar Legend's 'Bad Nights' on the Road
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
Drug Science and UCL collaborate to refine MDMA-assisted therapy, addressing FDA concerns and enhancing psychotherapeutic practices for improved treatment outcomes.
Psychedelic Church Opens In Colorado Springs, CO Making History
Meet Colorado's first psychedelic church in Colorado Springs, where magic mushrooms and DMT are used for healing and creating community.